Table 2.

Intensity of VDR expression in colorectal cancer and mutations in PIK3CA and KRAS

Total nVDR expression
NoWeakModerateStrong
PIK3CA mutation
    (−)470 (85%)179 (89%)140 (87%)98 (80%)53 (78%)
    (+)84 (15%)23 (11%)21 (13%)25 (20%)15 (22%)
KRAS mutation
    (−)388 (63%)154 (70%)110 (62%)79 (57%)45 (56%)
    (+)229 (37%)66 (30%)67 (38%)60 (43%)36 (44%)

NOTE: A percentage number indicates the frequency of PIK3CA or KRAS mutation among colorectal cancers in a specific category of VDR expression intensity.